Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunlin Zhou

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Blood Cancer Journal|May 27, 2026
Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patientsHeng Shen, Yan Hui, Yuntao Liu, et al.
Blood|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic LeukemiaXiaoyuan Gong, Yuntao Liu, Qiuyun Fang, et al.
Plos One|July 6, 2017
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemiaRunxia Gu, Hui Wei, Ying Wang, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Haematologica|October 15, 2020
Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemiaHui Wei, Chunlin Zhou, Dong Lin, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Leukemia|September 5, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Frontiers in Oncology|June 21, 2021
Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic LeukemiaQiuyun Fang, Yang Song, Xiaoyuan Gong, et al.
Haematologica|March 19, 2026
The prognostic role of myeloid-related gene mutations in adult acute lymphoblastic leukemiaWenting Wang, Jiayuan Chen, Yan Li, et al.
Leukemia|June 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Blood Cancer Journal|May 27, 2026
Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patientsHeng Shen, Yan Hui, Yuntao Liu, et al.
Blood|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic LeukemiaXiaoyuan Gong, Yuntao Liu, Qiuyun Fang, et al.
Plos One|July 6, 2017
The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemiaRunxia Gu, Hui Wei, Ying Wang, et al.
Blood Science (Baltimore, Md.)|May 14, 2024
The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/<i>FUS::ERG</i>Anli Lai, Wenbing Liu, Hui Wei, et al.
Haematologica|October 15, 2020
Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemiaHui Wei, Chunlin Zhou, Dong Lin, et al.
Experimental Hematology|February 1, 2021
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1Hui Wei, Xueou Liu, Ying Wang, et al.
Leukemia|September 5, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Frontiers in Oncology|June 21, 2021
Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic LeukemiaQiuyun Fang, Yang Song, Xiaoyuan Gong, et al.
Haematologica|March 19, 2026
The prognostic role of myeloid-related gene mutations in adult acute lymphoblastic leukemiaWenting Wang, Jiayuan Chen, Yan Li, et al.
Leukemia|June 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trialXiaoyuan Gong, Wenbing Liu, Yuntao Liu, et al.
Pageof 7